Cullinan Therapeutics, Inc. (CGEM)
15.51
+0.98
(+6.74%)
USD |
NASDAQ |
Oct 02, 16:00
15.55
+0.04
(+0.26%)
Pre-Market: 08:56
Cullinan Therapeutics EPS Diluted (Quarterly) : -0.8666 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.8666 |
| March 31, 2026 | -0.8139 |
| December 31, 2025 | -0.8566 |
| September 30, 2025 | -0.8567 |
| June 30, 2025 | -1.187 |
| March 31, 2025 | -0.8234 |
| December 31, 2024 | -0.8134 |
| September 30, 2024 | -0.6953 |
| June 30, 2024 | -0.7634 |
| March 31, 2024 | -0.8637 |
| December 31, 2023 | -0.5562 |
| September 30, 2023 | -0.9169 |
| June 30, 2023 | -0.8063 |
| March 31, 2023 | -1.425 |
| Date | Value |
|---|---|
| December 31, 2022 | -0.5854 |
| September 30, 2022 | -0.5438 |
| June 30, 2022 | 3.771 |
| March 31, 2022 | -0.2723 |
| December 31, 2021 | -0.7341 |
| September 30, 2021 | -0.3974 |
| June 30, 2021 | -0.3592 |
| March 31, 2021 | -0.0017 |
| December 31, 2020 | -0.6514 |
| September 30, 2020 | -0.2265 |
| June 30, 2020 | -0.1981 |
| March 31, 2020 | -0.2653 |
| December 31, 2019 | -0.105 |
| September 30, 2019 | -0.98 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Climb Bio, Inc. | -0.1772 |
| MapLight Therapeutics, Inc. | -1.325 |
| Arrowhead Pharmaceuticals, Inc. | -1.355 |
| Oncolytics Biotech, Inc. | -0.0788 |
| Sangamo Therapeutics, Inc. | -0.0796 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -53.70M |
| Total Expenses (Quarterly) | 53.70M |
| Enterprise Value | 668.70M |
| Earnings Yield | -21.88% |
| Normalized Earnings Yield | -21.88 |